This article is a retraction of:
RETRACTED: Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
Frontiers Editorial OfficeA Retraction of the Original Research Article
Oncological effects and prognostic value of AMAP1 in gastric cancer
by Li J, Tian S, Guo Y and Dong W (2021). Front. Genet. 12:675100. doi: 10.3389/fgene.2021.675100
The journal retracts the 17 June 2021 article cited above.
Following publication, Frontiers was alerted to the presence of non-verifiable cell line identifiers in this publication. Upon further examination, it was determined that core findings of this study were obtained using non-verifiable cell lines and/or cell lines known to be cross-contaminated with HeLa. This contamination compromises the data and conclusions of the article and the article has been retracted.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and do not agree to this retraction. This communication has been recorded by the publisher.
Citation: Frontiers Editorial Office (2024) Retraction: Oncological effects and prognostic value of AMAP1 in gastric cancer. Front. Genet. 15:1491856. doi: 10.3389/fgene.2024.1491856
Received: 05 September 2024; Accepted: 05 September 2024;
Published: 11 September 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org